Yan Liu

Dr. Yan Liu


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Biology Open
Verified
Journal Article
Open access
PDF file
YZYiqing Zhu
Yiqing Zhu
YLYan Liu
Yan Liu
BXBang Xiao
Bang Xiao
HCHui Cai
Hui Cai
MLMeng Liu
Meng Liu
FWFang Wang
Fang Wang
Accumulating evidence suggests that circular RNAs (circRNAs) play important roles in various physiological and pathological processes. In the present study, we explored the role of circRNA PVT1 in hepatocellular carcinoma (HCC). qRT-PCR was performed to detect the relative expression of circPVT1 in HCC tissues and cell lines. The oncogenic roles of circPVT1 in HCC were evaluated by cell counting kit-8 (CCK-8) assay, ethynyl deoxyuridine (EdU) incorporation assays, transwell assays, flow cytometry and in vivo xenograft growth. Furthermore, bioinformatics, luciferase reporter assays and rescue experiments were conducted to determine the underlying mechanism of circPVT1 in HCC. Enhanced circPVT1 expression was detected in HCC tissues, which was closely associated with poor prognosis of patients with HCC. Knockdown of circPVT1 decreased the proliferation and migration ability of HCC cell lines in vitro. Conversely, upregulation of circPVT1 improved the growth and migration in HCC cells. Mechanistically, we found that circPVT1 could bind directly to miR-203 and contributed to the initiation and progression of HCC by regulating miR-203/homebox D3 (HOXD3) pathway. In conclusion, our study reveals that circPVT1 participates in the progression of HCC through the miR-203/homeobox D3 (HOXD3) pathway and might represent a potential therapeutic target for HCC treatment.

1 December 2024 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
YDYingying Du
Yingying Du
YLYan Liu
Yan Liu
TLTong Liu
Tong Liu
FPFen Pan
Fen Pan
SMShikui Mu
Shikui Mu
SWSheng Wang
Sheng Wang
Objective: This study aimed to evaluate the in vitro activity of omadacycline (OMC) and OMC-based combination therapy against carbapenem-resistant Klebsiella pneumoniae (CRKP). Methods: The broth microdilution assay assessed the in vitro susceptibility of CRKP to OMC. The checkerboard assay was performed to evaluate the activity of OMC combined with polymyxin B (PB), amikacin (AN), or meropenem (MEM) against KPC-producing (class A) CRKP strains, and OMC combined with PB, aztreonam (ATM), MEM, or AN against class B and class A plus class B CRKP strains. Synergistic effects of OMC and PB were further evaluated by time-kill assays in the KPC-producing CRKP strains. Results: Broth microdilution assays revealed a notable variation in susceptibility between KPC-producing and class B CRKP strains, with MIC50/90 of 32/32 mg/L and 0.5/8 mg/L, respectively. Although KPC-producing CRKP strains were resistant to OMC, a synergistic effect was observed in 37.5% of KPC-producing CRKP strains when OMC was combined with PB. In the nine KPC-producing CRKP strains, time-kill assays found that cell densities of six strains (66.7%) decreased by 3.61 ± 0.23 log10 CFU/mL compared to the initial inoculum after 2 hours of PB exposure. The cell densities further decreased by an average of 2.38 ± 0.23 log10 CFU/mL when the six strains were exposed to OMC plus PB, confirming their potent synergism. Conclusion: OMC monotherapy is ineffective against KPC-producing CRKP strains, but OMC plus PB has a potent synergistic effect on them, suggesting that OMC plus PB is the preferred combination therapy against KPC-producing CRKP in vitro.

1 July 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JXJing Xia
Jing Xia
JYJue Yu
Jue Yu
WSWenwen Shi
Wenwen Shi
YLYan Liu
Yan Liu
Bone regeneration is a critical area of research in the treatment of bone defects within clinical practice. Molybdenum (Mo) is an essential trace element for many organisms, which plays a vital role in various cellular activities, such as maintaining energy metabolism and promoting cell proliferation. However, whether Mo regulates the osteogenic differentiation of periodontal ligament stem cells (PDLSCs) and promotes bone tissue regeneration remains unknown. This study confirmed the nourishing effect of Mo on the osteogenic differentiation of PDLSCs, as evidenced by higher expression of osteogenic-related markers (OCN, BSP, OSX and RUNX2), ALP activity and mineralization ability. Moreover, through constructing compound material GelMA + PDLSC, we proved that Mo promoted PDLSC-based bone regeneration quantity and quality in rat calvarial defects. Finally, we revealed the underlying mechanism that the JAK/STAT3 signaling pathway actively participated in the Mo-enhanced osteogenic differentiation of PDLSCs. The inhibition of STAT3 diminished the benefit of Mo. Overall, our study found that Mo facilitated PDLSC-based bone regeneration through the JAK/STAT3 signaling pathway, which may shed new light on clinical bone regeneration therapeutic strategies.

1 January 2022 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
YDYingying Du
Yingying Du
SMShikui Mu
Shikui Mu
YLYan Liu
Yan Liu
YYYinghua Yuan
Yinghua Yuan
YZYunlou Zhu
Yunlou Zhu
SWSheng Wang
Sheng Wang
Purpose: This study retrospectively analyzed the genome characteristics of blaKPC-2 in multidrug-resistant Klebsiella pneumoniae collected from the ICU of a teaching hospital in Shanghai, China. Methods: From February 2018 to December 2019, 36 strains of multidrug-resistant Klebsiella pneumoniae were collected from the bronchoalveolar lavage fluid of critically ill patients. The genome of all isolates was obtained through the Illumina sequence, and single nucleotide polymorphisms of the blaKPC-2 gene were analyzed to explore blaKPC-2’s evolutionary characteristics. Different strains’ genetic relationships and homology were studied by constructing an evolutionary tree on a single copy orthologue. Pacbio combined Illumina sequence was conducted to evaluate the structure and potential mobility of drug-resistant plasmids of the strain KP-s26. Results: The distribution of resistance and virulence genes had little difference, but most strains had significant differences in the plasmid-encoded region. Most strains (31/36) carried the carbapenemase gene blaKPC-2, with no single nucleotide polymorphism in different strains. Extended-spectrum β-lactamase resistance genes, such as blaCTX-M and blaSHV, were found in the isolates, but no metallo-β-lactamases were detected. All strains with blaKPC-2 coexisted with chromosomal-associated fosfomycin resistance genes fosA6, and the coexistence of blaKPC-2 and blaCTX variants (blaCTX-M-15, blaCTX-M-65, and blaCTX-M-27) was also detected in 29/31 strains. The isolate KP-s26 carried five circular plasmids. pA and pB were conjugate plasmids, as they carried drug resistance genes and contained a complete IV secretion system. Conclusion: The blaKPC-2 carbapenemase gene is relatively conservative in the process of evolution; drug-resistant plasmids containing conjugated transfer elements contribute to the spreading of drug resistance. The coexistence of blaKPC-2 with fosA6 or blaCTX-M variants was associated with increased fosfomycin resistance and broad-spectrum β-lactam resistance, respectively. Clinical Trials Registration: Clinical Trials.gov Identifier: NCT03950544